Preliminary Efficacy and Safety of INNO-206 Compared to Doxorubicin in Advanced Soft Tissue Sarcoma

Clinical trial NCT01514188 · COMPLETED

Trial details

NCT number: NCT01514188
Sponsor: ImmunityBio, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Soft Tissue Sarcoma Locally Advanced Soft Tissue Sarcoma Unresectable Soft Tissue Sarcoma

Start date: 2012-01-11
Primary completion: 2014-04-09
Enrollment: 126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.